BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15954536)

  • 1. Possible role of procathepsin D in human cancer.
    Vashishta A; Fusek M; Vetvicka V
    Folia Microbiol (Praha); 2005; 50(1):71-6. PubMed ID: 15954536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procathepsin D as a tumor marker, anti-cancer drug or screening agent.
    Vetvicka V; Fusek M
    Anticancer Agents Med Chem; 2012 Feb; 12(2):172-5. PubMed ID: 22292775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procathepsin D and cytokines influence the proliferation of lung cancer cells.
    Vetvicka V; Vetvickova J
    Anticancer Res; 2011 Jan; 31(1):47-51. PubMed ID: 21273579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenic function of human procathepsin D: the role of the propeptide.
    Fusek M; Vetvicka V
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):775-80. PubMed ID: 7980446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin D--many functions of one aspartic protease.
    Benes P; Vetvicka V; Fusek M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):12-28. PubMed ID: 18396408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the propeptide on procathepsin D activation of human peripheral lymphocytes and neutrophils.
    Vaclav V; Jana V; Martin F
    Arch Biochem Biophys; 1995 Sep; 322(1):295-8. PubMed ID: 7574690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Anticancer Res; 2006; 26(6B):4163-70. PubMed ID: 17201128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development.
    Vetvicka V; Vetvickova J; Fusek M
    Breast Cancer Res Treat; 1999 Oct; 57(3):261-9. PubMed ID: 10617302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procathepsin D secreted by HaCaT keratinocyte cells - A novel regulator of keratinocyte growth.
    Vashishta A; Saraswat Ohri S; Vetvickova J; Fusek M; Ulrichova J; Vetvicka V
    Eur J Cell Biol; 2007 Jun; 86(6):303-13. PubMed ID: 17532541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects.
    Fusek M; Vetvickova J; Vetvicka V
    J Interferon Cytokine Res; 2007 Mar; 27(3):191-9. PubMed ID: 17348817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of enzymatically inactive procathepsin D in lung cancer.
    Vetvicka V; Vetvickova J; Benes P
    Anticancer Res; 2004; 24(5A):2739-43. PubMed ID: 15517880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells.
    Vetvicka V; Vetvickova J; Hilgert I; Voburka Z; Fusek M
    Int J Cancer; 1997 Nov; 73(3):403-9. PubMed ID: 9359488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peripheral blood neutrophils and lymphocytes by human procathepsin D and insulin-like growth factor II.
    VÄ•tvicka V; Fusek M
    Cell Immunol; 1994 Jul; 156(2):332-41. PubMed ID: 8025952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procathepsin D and cancer: From molecular biology to clinical applications.
    Vetvicka V; Vashishta A; Saraswat-Ohri S; Vetvickova J
    World J Clin Oncol; 2010 Nov; 1(1):35-40. PubMed ID: 21603309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors.
    Vetvicka V; Benes P; Fusek M
    Cancer Gene Ther; 2002 Oct; 9(10):854-63. PubMed ID: 12224027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines.
    Ohri SS; Vashishta A; Vetvickova J; Fusek M; Vetvicka V
    Int J Biol Macromol; 2007 Jul; 41(2):204-9. PubMed ID: 17397917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A procathepsin D specific monoclonal antibody that recognizes procathepsin D but not cathepsin D.
    Kopitar-Jerala N; Turk V
    Immunol Lett; 1999 Dec; 70(3):211-2. PubMed ID: 10656676
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Autocatalytic proteolysis of the zymogen form of the enzyme.
    Conner GE
    Biochem J; 1989 Oct; 263(2):601-4. PubMed ID: 2512908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of procathepsin D activation peptide in prostate cancer growth.
    Vetvicka V; Vetvickova J; Fusek M
    Prostate; 2000 Jun; 44(1):1-7. PubMed ID: 10861751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.